血红素铁与亚铁盐治疗冈比亚儿童缺铁性贫血:随机对照试验方案
世界卫生组织推荐在贫血率超过40%的国家为6-23月龄儿童普遍补铁。本随机对照试验将在冈比亚6-12月龄贫血儿童中比较每日补充10.0 mg元素铁(血红素铁或硫酸亚铁)12周对血红蛋白和血清铁蛋白的影响,并评估腹泻和感染相关不良事件。
要点
- 传统亚铁盐在炎症儿童中因口服吸收低而疗效有限,血红素铁生物利用度更高且吸收可能不受炎症影响。
- 研究为两臂随机对照试验,6-12月龄贫血儿童按1:1比例随机接受每日10.0 mg元素铁(血红素铁或硫酸亚铁)补充12周。
- 主要分析采用改良意向性治疗(随机且至少摄入一剂铁补充剂),调整基线C反应蛋白、α1-酸性糖蛋白、血红蛋白、铁蛋白、可溶性转铁蛋白受体等协变量。
核心结论
- 本研究旨在确定治疗性补充血红素铁是否比亚铁盐更能提高6-12月龄贫血儿童的血红蛋白和铁蛋白浓度。
研究设计与样本
- 两臂随机对照试验,在冈比亚 predefined 地理区域内招募6-12月龄贫血儿童,由训练有素的现场工作人员招募。
- 合格参与者按1:1比例采用置换区组个体随机,每日补充10.0 mg元素铁(血红素铁或硫酸亚铁)共12周。
- 安全性结局如腹泻和感染相关不良事件由临床团队每日评估。
关键数值与推荐
- 主要结局为补充12周后的血红蛋白浓度和血清铁蛋白浓度。
- 连续结局采用线性回归分析,必要时对残差进行对数转换以使其正态化;二分类结局采用二项回归或逻辑回归分析。
- 主要分析采用改良意向性治疗(随机且至少摄入一剂铁补充剂),并用多重插补替换缺失数据。
- 效应估计调整基线协变量:C反应蛋白、α1-酸性糖蛋白、血红蛋白、铁蛋白、可溶性转铁蛋白受体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization recommends universal iron supplementation for children aged 6-23 months in countries where anaemia is seen in over 40% of the population. Conventional ferrous salts have low efficacy due to low oral absorption in children with inflammation. Haem iron is more bioavailable, and its absorption may not be decreased by inflammation. This study aims to compare daily supplementation with haem iron versus ferrous sulphate on haemoglobin concentration and serum ferritin concentration after 12 weeks of supplementation. METHODS: This will be a two-arm, randomised controlled trial. Gambian children aged 6-12 months with anaemia will be recruited within a predefined geographical area and recruited by trained field workers. Eligible participants will be individually randomised using a 1:1 ratio within permuted blocks to daily supplementation for 12 weeks with either 10.0 mg of elemental iron as haem or ferrous sulphate. Safety outcomes such as diarrhoea and infection-related adverse events will be assessed daily by the clinical team (see Bah et al. Additional file 4_Adverse event eCRF). Linear regression will be used to analyse continuous outcomes, with log transformation to normalise residuals as needed. Binary outcomes will be analysed by binomial regression or logistic regression, Primary analysis will be by modified intention-to-treat (i.e., those randomised and who ingested at least one supplement dose of iron), with multiple imputations to replace missing data. Effect estimates will be adjusted for baseline covariates (C-reactive protein, alpha-1-acid glycoprotein, haemoglobin, ferritin, soluble transferrin receptor). DISCUSSION: This study will determine if therapeutic supplementation with haem iron is more efficacious than with conventional ferrous sulphate in enhancing haemoglobin and ferritin concentrations in anaemic children aged 6-12 months. TRIAL REGISTRATION: Pan African Clinical Trial Registry PACTR202210523178727.
引用
- Bah M, Verhoef H, Okoh E, et al. Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children: protocol for randomised controlled trial {1}. Trials. 2024. PMID: 38641845. doi:10.1186/s13063-024-08101-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。